Exact Mass: 619.0928

Exact Mass Matches: 619.0928

Found 25 metabolites which its exact mass value is equals to given mass value 619.0928, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

gdp-D-mannuronate

GDP-D-mannuronate; GDP-D-mannuronic acid

C16H23N5O17P2 (619.0564)


   

ADP-D-Glycero-D-manno-heptose

ADP-D-glycero-beta-D-manno-heptose

C17H27N5O16P2 (619.0928)


   

UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uloseuronic acid

UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate; UDP-3-keto-GlcNAcA

C17H23N3O18P2 (619.0452)


   

ADP-L-glycero-D-manno-heptose

ADP-L-glycero-beta-D-manno-heptose

C17H27N5O16P2 (619.0928)


An ADP-glycero-D-manno-heptose having L-glycero-configuration at the 6-position of the heptose portion.

   

Relcovaptan (SR-49059)

1-[5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulphonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]pyrrolidine-2-carboximidic acid

C28H27Cl2N3O7S (619.0947)


   
   

NO-Indomethacin

N-acetyl-D-cysteine-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid, 4-(nitrooxy)butyl ester

C28H30ClN3O9S (619.1391)


   

PHTHALOCYANINE SILVER

PHTHALOCYANINE SILVER

C32H16AgN8 (619.0549)


   

CHLORODICARBONYL[1-(I-PROPYLAMINO)-2,3,4,5-TETRAPHENYLCYCLOPENTADIENYL]RUTHENIUM(II)

CHLORODICARBONYL[1-(I-PROPYLAMINO)-2,3,4,5-TETRAPHENYLCYCLOPENTADIENYL]RUTHENIUM(II)

C34H28ClNO2Ru (619.0852)


   

Relcovaptan

Relcovaptan

C28H27Cl2N3O7S (619.0947)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

1,2,3-Tri-O-benzoyl-α-L-fucopyranose, Trichloroacetimidate

1,2,3-Tri-O-benzoyl-α-L-fucopyranose, Trichloroacetimidate

C29H24Cl3NO8 (619.0567)


   
   

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate

C17H27N5O16P2 (619.0928)


   

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate

C17H27N5O16P2 (619.0928)


   

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl] hydrogen phosphate

C17H27N5O16P2 (619.0928)


   

[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] (2S,3R,4R,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoate

[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] (2S,3R,4R,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoate

C16H23N5O17P2 (619.0564)


   

GDP-D-Mannuronic acid

GDP-D-Mannuronic acid

C16H23N5O17P2 (619.0564)


   

[[[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] 2,3,4,5-tetrahydroxy-6-oxohexanoate

[[[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] 2,3,4,5-tetrahydroxy-6-oxohexanoate

C16H23N5O17P2 (619.0564)


   

ADP-L-glycero-beta-D-manno-heptose

ADP-L-glycero-beta-D-manno-heptose

C17H27N5O16P2 (619.0928)


An ADP-L-glycero-D-manno-heptose having beta-configuration at the anomeric centre of the heptose.

   

GDP-alpha-D-mannuronic acid

GDP-alpha-D-mannuronic acid

C16H23N5O17P2 (619.0564)


   

ADP-D-glycero-beta-D-manno-heptose

ADP-D-glycero-beta-D-manno-heptose

C17H27N5O16P2 (619.0928)


The beta-anomer of ADP-D-glycero-D-manno-heptose.

   

GDP-6-deoxy-D-manno-heptose

GDP-6-deoxy-D-manno-heptose

C17H27N5O16P2 (619.0928)


   

Glutaminase-IN-1

Glutaminase-IN-1

C26H24F3N7O3Se (619.1058)


Glutaminase-IN-1 (CB839 derivative), a CB839 derivative, is an allosteric inhibitor of 1,3,4-selenadiazole-containing kidney-type glutaminase (KGA), with an IC50 of 1 nM. Glutaminase-IN-1 (CB839 derivative) shows improved cellular uptake and antitumor activity.

   

{[(2s,3s,4r,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2s,3r,4s,5s,6s)-6-[(1r)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy)phosphinic acid

{[(2s,3s,4r,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2s,3r,4s,5s,6s)-6-[(1r)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy)phosphinic acid

C17H27N5O16P2 (619.0928)


   

{[(2s,3r,4r,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2r,3s,4s,5s,6s)-6-[(1s)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy)phosphinic acid

{[(2s,3r,4r,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy([(2r,3s,4s,5s,6s)-6-[(1s)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy)phosphinic acid

C17H27N5O16P2 (619.0928)